Cart
sales@molnova.com
Kaempferol 3-O-β-D-glucuronide
CAS No. 22688-78-4
Kaempferol 3-O-β-D-glucuronide( Kaempferol-3-beta-O-glucuronide | Kaempferol-3-glucuronide | Kaempferol-3-O-glucuronide )
Catalog No. M29175 CAS No. 22688-78-4
Kaempferol 3-O-β-D-glucuronidee has antioxidant activity. Flavonoid glucuronides can be deconjugated by microsomal α2-glucuronidase from various human cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 271 | In Stock |
|
| 5MG | 264 | In Stock |
|
| 10MG | 391 | In Stock |
|
| 25MG | 652 | In Stock |
|
| 50MG | 909 | In Stock |
|
| 100MG | 1228 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKaempferol 3-O-β-D-glucuronide
-
NoteResearch use only, not for human use.
-
Brief DescriptionKaempferol 3-O-β-D-glucuronidee has antioxidant activity. Flavonoid glucuronides can be deconjugated by microsomal α2-glucuronidase from various human cells.
-
DescriptionKaempferol 3-O-β-D-glucuronidee has antioxidant activity. Flavonoid glucuronides can be deconjugated by microsomal α2-glucuronidase from various human cells.(In Vitro):Kaempferol-3-o-β-d-glucuronate exhibit potential anti-inflammatory effect in LPS stimulated RAW 264.7 cells.(In Vivo):Kaempferol-3-o-β-d-glucuronate exhibit potential anti-inflammatory effect in mice model.
-
In Vitro——
-
In Vivo——
-
SynonymsKaempferol-3-beta-O-glucuronide | Kaempferol-3-glucuronide | Kaempferol-3-O-glucuronide
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorIL Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22688-78-4
-
Formula Weight462.363
-
Molecular FormulaC21H18O12
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (216.28 mM)
-
SMILESO[C@H]1[C@H](Oc2c(oc3cc(O)cc(O)c3c2=O)-c2ccc(O)cc2)O[C@@H]([C@@H](O)[C@@H]1O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
NFAT inhibitor, Cell...
NFAT inhibitor. Inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). Also attenuates NO production and Nos2 mRNA expression in LPS-stimulated BMDMs. Improves symptoms in a mouse model of colitis. Exhibits immunosuppressive effects; enhances graft survival in mice. Cell permeable.
-
Sarilumab
Sarilumab （SAR-153191）is a potent interleukin-6 IL-6 receptor antagonist and a human immunoglobulin G1 monoclonal antibody. Sarilumab inhibits IL-6-mediated signaling and reduces inflammation.Sarilumab is used for the prevention and treatment of rheumatoid arthritis.
-
Daclizumab
Daclizumab (Zenapax) is a humanized monoclonal antibody that specifically inhibits the alpha subunit of IL-2R-HA.
